Genomewide Significant Linkage to Recurrent, Early-Onset Major Depressive Disorder on Chromosome 15q  by Holmans, Peter et al.
Am. J. Hum. Genet. 74:1154–1167, 2004
1154
Genomewide Signiﬁcant Linkage to Recurrent, Early-Onset Major
Depressive Disorder on Chromosome 15q
Peter Holmans,1 George S. Zubenko,2 Raymond R. Crowe,3 J. Raymond DePaulo Jr.,4
William A. Scheftner,5 Myrna M. Weissman,6 Wendy N. Zubenko,2 Sandra Boutelle,3
Kathleen Murphy-Eberenz,7 Dean MacKinnon,4 Melvin G. McInnis,4 Diana H. Marta,5
Philip Adams,6 James A. Knowles,6 Madeleine Gladis,7 Jo Thomas,4 Jennifer Chellis,4
Erin Miller,4 and Douglas F. Levinson7
1Biostatistics and Bioinformatics Unit, University of Wales College of Medicine, Cardiff, United Kingdom; MRC Biostatistics Unit, Cambridge,
United Kingdom; 2Department of Psychiatry, University of Pittsburgh, Pittsburgh; 3Department of Psychiatry and Mental Health CRC,
University of Iowa, Iowa City; 4Department of Psychiatry, Johns Hopkins University, Baltimore; 5Department of Psychiatry, Rush University
Medical Center, Chicago; 6Department of Psychiatry, College of Physicians and Surgeons, Columbia University, and New York State
Psychiatric Institute, New York; and 7Department of Psychiatry and Center for Neurobiology and Behavior, University of Pennsylvania,
Philadelphia
A genome scan was performed on the ﬁrst phase sample of the Genetics of Recurrent Early-Onset Depression
(GenRED) project. The sample consisted of 297 informative families containing 415 independent affected sibling
pairs (ASPs), or, counting all possible pairs, 685 informative affected relative pairs (555 ASPs and 130 other pair
types). Affected cases had recurrent major depressive disorder (MDD) with onset before age 31 years for probands
or age 41 years for other affected relatives; the mean age at onset was 18.5 years, and the mean number of depressive
episodes was 7.3. The Center for Inherited Disease Research genotyped 389 microsatellite markers (mean spacing
of 9.3 cM). The primary linkage analysis considered allele sharing in all possible affected relative pairs with the
use of the Zlr statistic computed by the ALLEGRO program. A secondary logistic regression analysis considered
the effect of the sex of the pair as a covariate. Genomewide signiﬁcant linkage was observed on chromosome
15q25.3-26.2 ( , equivalent LOD p 3.73, empirical genomewide ). The linkage was not sexZ p 4.14 Pp .023lr
speciﬁc. No other suggestive or signiﬁcant results were observed in the primary analysis. The secondary analysis
produced three regions of suggestive linkage, but these results should be interpreted cautiously because they depended
primarily on the small subsample of 42 male-male pairs. Chromosome 15q25.3-26.2 deserves further study as a
candidate region for susceptibility to MDD.
Introduction
We report here on a genome scan of the ﬁrst phase of
a large repository-based study of families multiply af-
fected with recurrent, early-onset major depressive dis-
order (MDD, unipolar depression) (Levinson et al.
2003). MDD is a multifactorial disorder with moderate
heritability. Family and twin studies suggest that the
greatest relative risk for MDD, compared with the risk
of the general population, probably is observed in fam-
ilies of probands with early age at onset and/or recurrent
episodes. The present study is designed to map suscep-
tibility genes in families with these features. Clinical data
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collection has been completed. For the primary diag-
nostic model, with consideration of only cases of recur-
rent, early-onset MDD as deﬁned below, the ﬁnal sample
(prior to genetic analyses to conﬁrm family structures
for the last part of the sample) includes 665 informative,
predominantly European-ancestry pedigrees containing
921 independent affected sibling pairs (ASPs) and ad-
ditional affected relatives. This ﬁrst report considers 297
families containing 415 ASPs that were informative for
linkage analysis under this model. The remaining fam-
ilies currently are being genotyped by the Center for
Inherited Disease Research (CIDR), and results will be
reported later in 2004. DNA and blinded clinical data
from this sample will be made available by the National
Institute of Mental Health (NIMH) Center for Collab-
orative Genetics Studies of Mental Disorders (see NIMH
CGSMD Web site) during 2004.
MDD is a common disorder associated with increased
mortality, particularly because of suicide (reviewed in
Schneider et al. [2001]). It is also the leading cause of
worldwide disability for individuals 15–44 years of age
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(World Health Organization 1996). The major depres-
sive syndrome is characterized by 2 wks of depressed
mood and/or reduced or absent capacity for pleasure,
accompanied by additional symptoms, such as dis-
turbed sleep and appetite, reduced concentration and
energy, excessive guilt, slowed or agitated movements,
and suicidal thoughts or acts (American Psychiatric As-
sociation 1994). Estimates of lifetime prevalence range
from 2%–19% (Moldin et al. 1991; Tsuang et al. 1994;
Weissman et al. 1996). Two recent, large U.S. popula-
tion surveys (National Comorbidity Survey [NCS] and
NCS-Replication) demonstrated similar lifetime preva-
lences of 17.1% (Kessler et al. 1994) and 16.2% (Kes-
sler et al. 2003). Prevalence is increasing in younger
generations (Klerman and Weissman 1989; Lewinsohn
et al. 1993; Kessler and Walters 1998; Kessler et al.
2003), apparently owing to increased MDD comorbid
with other disorders, rather than “pure” MDD (Kessler
et al. 1996). A ratio of MDD in women versus in men
of 2:1 generally is observed.
Adoption studies conﬁrm the role for genetic factors
(Mendlewicz and Rainer 1977; Cadoret 1978; Wender
et al. 1986). The high ratio of correlation in liability
between MZ versus DZ twin pairs suggests multigenic
inheritance, although evidence for major locus effects
has been reported in some studies (Price et al. 1987;
Cox et al. 1989; Marazita et al. 1997; Maher et al.
2002). A meta-analysis of twin studies suggested an
overall heritability of .37 (Sullivan et al. 2000); esti-
mates have been as high as .70, in community samples
assessed twice over time (Kendler et al. 1993a), and .79,
in adolescent twins (Thapar and McGufﬁn 1994). One
large community-based twin study suggested greater
heritability in women (Bierut et al. 1999). A second
similar study could not differentiate clearly between the
hypotheses of equal or different heritabilities, and it
suggested that there was a 70% overlap in the genetic
factors contributing to MDD in men and women (Ken-
dler et al. 2001). The sex of an MDD proband has not
been reported to determine the ratio of risk of MDD in
male and female siblings and offspring.
Some individuals who experience major depressive
episodes also have episodes of mania or hypomania
(manic syndrome without substantial functional im-
pairment), receiving diagnoses of bipolar-I (BP-I) and
BP-II disorder, respectively (American Psychiatric As-
sociation 1994). The lifetime prevalence of a manic ep-
isode was 1.6% in the NCS (Kessler et al. 1994). The
genetic relationships among MDD, BP-I, and BP-II re-
main unclear. First-degree relatives of BP-I and BP-II
probands are at increased risk of both unipolar and
bipolar disorders, but the relatives of MDD probands
are not at increased risk of BP-I (Gershon et al. 1982;
Maier et al. 1993; Tsuang et al. 1994), and males and
females are at equal risk of BP-I, suggesting that uni-
polar and bipolar disorders are at least partially inde-
pendent genetically. The status of BP-II is less clear. Rel-
atives of BP-II probands are at greater risk of BP-II than
of BP-I (Simpson et al. 1993; Heun and Maier 1993;
Endicott et al. 1985), and BP-II cases lie between BP-I
and MDD in clinical features (Coryell et al. 1985a) and
in the rates of BP-I and MDD in probands’ families
(Gershon et al. 1982; Endicott et al. 1985). It has been
difﬁcult to differentiate reliably between BP-II and
MDD with the use of current methods (Rice et al. 1986;
Leboyer et al. 1991), although reliability is better for
highly trained interviewers (Simpson et al. 2002).
First-degree relatives of MDD probands are at an ∼2–
3-fold increased risk of MDD compared with the gen-
eral population (Gershon et al. 1982; Weissman et al.
1984; Maier et al. 1993; Merikangas et al. 2002). Two
clinical features of probands have been reported to pre-
dict a greater increase of MDD risk in ﬁrst-degree rel-
atives: recurrent episodes and early age at onset (AO).
A relationship between recurrent episodes and familial
risk has been reported in at least six studies (Bland et
al. 1986; Gershon et al. 1986; Stancer et al. 1987; Ken-
dler et al. 1994, 1999; McGufﬁn et al. 1996), but not
by Weissman et al. (1986). Increased familial risk for
earlier-onset probands has been observed in at least nine
studies (Cadoret et al. 1978; Mendlewicz and Baron
1981; Weissman et al. 1986, 1987, 1993; Bland et al.
1986; Stancer et al. 1987; Kupfer et al. 1989; Lyons et
al. 1998), but not by Kendler et al. (1994, 1999) or
McGufﬁn et al. (1987, 1996). Only one study reported
an analysis of an interaction between earlier AO and
recurrence: Bland et al. (1986) observed a morbidity
risk for MDD of 17.4% in ﬁrst-degree relatives of pro-
bands with recurrent, early-onset MDD (deﬁned as on-
set before the median AO of 51.2 years) versus 3.4%
in the relatives of probands with single episodes and
later onsets, with intermediate risks for relatives of
early-onset/single episode and later-onset/recurrent
MDD probands.
Epidemiological data are lacking to estimate the pop-
ulation prevalence of recurrent or early-onset recurrent
MDD or the recurrence risk in families of MDD pro-
bands; neither is there a clear cutoff for “early onset.”
The most detailed relevant study (Weissman et al. 1984)
reported that, for morbid risk of all MDD, ﬁrst-degree
relatives of probands with onset before age 20 years
had a recurrence risk of 5.0 compared with relatives of
control probands, and this decreased to 3.6 when the
proband’s onset was before age 30 years, 2.5 when it
was before age 40 years, and 1.6 when it was after age
40 years. The risk of MDD in relatives of earlier-onset
probands clearly rose through their 20s and 30s, and
leveled off after age 40 years. Data from this and other
family studies (Weissman et al. 1982, 1984, 1993; Bland
et al. 1986; Marazita et al. 1997; Maher et al. 2002)
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suggest that the recurrence risk to ﬁrst-degree relatives
for recurrent, early-onset MDD is in the range of 3–8.
On the basis of this reading of the literature, we as-
certained informative families through probands with
recurrent MDD and onset before age 31 years, with one
or more additional available siblings with recurrent
MDD and onset before age 41 years. We used ages 31
and 41 years as cutoffs, rather than ages 30 and 40
years, because familial risks of MDD decline gradually
as a function of the proband’s AO, and the slightly older
cutoffs increased the number of eligible families without
substantially decreasing the reported relative risk of
MDD in the families. Cases with a parent or sibling
with BP-I were excluded to differentiate this sample
clearly from the many bipolar disorder pedigree stud-
ies, but relatives (not probands) with BP-II disorder
were recruited if they otherwise met age at onset and
depression-recurrence criteria, and, subsequently, these
cases were entered into secondary analyses.
Material and Methods
Eligibility and Recruitment of Subjects
Subject eligibility and clinical data collection proce-
dures have been described in detail elsewhere (Levinson
et al. 2003). In brief, subjects were recruited at six sites
(University of Iowa [Iowa], Johns Hopkins University
[JHU], New York State Psychiatric Institute [NYSPI],
University of Pennsylvania [Penn], University of Pitts-
burgh [Pitt], and Rush-Presbyterian Medical Center in
Chicago [Rush]) where uniform criteria and procedures
were used. All subjects gave informed consent following
IRB-approved protocols. Ascertainment was opportun-
istic, with each site seeking eligible families through co-
operating mental health facilities (predominantly out-
patient clinics and practices), primary care medical
settings, and self referrals in response to Web site an-
nouncements, media articles, and advertisements. Inclu-
sion/exclusion criteria are summarized in table 1. Pro-
spective probands were screened to identify those who
had at least one sibling with an apparent history of de-
pression (whom they were willing to contact about the
study), with no sibling or parent with a likely BP-I
diagnosis. Families were extended, where possible,
through ﬁrst-degree affected relatives. We included cases
with a single episode of MDD that persisted for 3
years. Individuals with no depressive episodes persisting
after age 18 years were excluded because of evidence
that MDD (often single episode) during adolescence is
common and might not be highly familial (Wickramar-
atne et al. 1998). Eligible cases were required to have
signiﬁcant reduction in major role performance notice-
able to others, which has been reported to be more char-
acteristic of familial MDD (Gershon et al. 1986). Cases
of MDD with psychotic features (5% of the sample,
most with mood-congruent psychotic features) were in-
cluded because familial risks of various psychiatric dis-
orders have been generally similar in families of psy-
chotic and nonpsychotic depressive probands (see, e.g.,
Coryell et al. [1985b] and Maier et al. [1992]).
In addition to affected cases, we attempted to obtain
blood specimens from all available parents, and, when
one or both parents were not available, from as many
as two additional siblings (unaffected or uninterested in
participating in the clinical study).
Clinical Assessment
Probands and relatives with reported histories of de-
pression were interviewed and narrative interview re-
ports were prepared by trained research clinicians (psy-
chologists, psychiatrists, social workers, and nurses with
psychiatric research training) with the use of the Diag-
nostic Interview for Genetic Studies (DIGS) (Nurnberger
et al. 1994), modiﬁed for mood-disorder studies (version
3.0). DIGS training was provided by the JHU group.
Study coordinators participated in regular conference
calls and meetings to discuss DIGS items and study cri-
teria. Most interviews were conducted by telephone.
Good reliability has been demonstrated for telephone
diagnoses of MDD compared with direct interview di-
agnoses (Simon et al. 1993; Sobin et al. 1993). At least
one and usually two family members also were inter-
viewed, with the use of the Family Interview for Genetic
Studies (FIGS) to obtain corroborating diagnostic in-
formation about participating individuals and to detect
BP-I in unavailable parents or siblings. Available parents
with no history of mood disorder detected by FIGS were
interviewed with a screening instrument (Kendler et al.
1993b) and then with DIGS if they reported such a his-
tory. Records of previous behavioral or medication treat-
ment were obtained with the subject’s consent. All sub-
jects (through interview or blood specimens) were asked
to complete the NEO Five-Factor Inventory (Costa and
McCrae 1986, 1988, 1992), a personality inventory.
Diagnostic Procedure
Two experienced research clinicians (not the inter-
viewer) reviewed all available data for each case (DIGS,
narrative report, FIGS, and available treatment records)
and recorded primary DSM-IV Best Estimate Final Di-
agnoses (Leckman et al. 1982; Klein et al. 1994). They
documented any additional diagnoses; the level of cer-
tainty and age at onset for each diagnosis; the number
of episodes and age at onset of major depression, hy-
pomania, mania, and mood congruent or incongruent
psychotic depression; the severity; the course of illness
(remitting, chronic/double depression, frequent/brief ep-
isodes, or other); and the timing of signiﬁcant comorbid
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Table 1
Inclusion/Exclusion Criteria
Criterion Probands Affected Relatives
Diagnosis DSM-IV Same
Recurrence 2 episodes required Same
Age at onset 30 years 40 years
Adult MDD 1 episode past age 18 Same
Impairment Major role impairment required Same
Psychiatric comorbidity Exclude schizophrenia, BP-I, ASPD,
and somatization disorder
Same
Substance abuse history MD episode before onset of abuse
or 2 years after abuse remission
MD episode before onset of abuse
or 1 year after abuse remission
Bipolar II Exclude pedigree if proband’s con-
sensus diagnosis is BP II
Include BP-II relatives with recurrent
MDD (secondary analyses only)
Family psychiatric history Exclude if positive FH of BP I in
sibling or parent
Same
alcohol or substance use (absent, onset after onset of
MDD, or, if onset was before MDD, then whether there
was at least one MDD episode following 1–2 years of
sobriety). Any disagreements between diagnosticians
about primary and secondary diagnoses or age at onset
were resolved through discussion or, rarely, through re-
view by a third diagnostician.
Collection of Blood Specimens and Creation of
Permanent Cell Lines
Blood specimens obtained from participating subjects
were sent by overnight courier to the NIMH Cell Re-
pository at Rutgers University, where Epstein-Barr virus-
transformed lymphoblastic permanent cell lines were
created, frozen, thawed, and regrown to ensure viability;
then, DNA was extracted.
Genotyping
Genotyping was performed by CIDR with the use of
standard semiautomated genotyping methods for ﬂuo-
rescent microsatellite markers (see CIDR Web site, lab
protocols). The genotyping was performed in two
phases. A genome map of 389 microsatellite markers
(see CIDRWeb site, marker information) was genotyped
in each phase, with three of the phase 1markers replaced
in phase 2. Average marker heterozygosity was 0.77 and
mean intermarker spacing was 9.30 cM. All DNA from
a family were genotyped in the same phase for consis-
tency of allele calls. In each phase, a 15-marker “forensic
panel” (2 X-chromosome, 2 Y-chromosome, and 11 au-
tosomal markers) was genotyped initially and analyzed
forMendelian inconsistencies, whichwere then reviewed
to identify and correct any sample swap errors and to
identify likely false paternities or other family structure
problems. The complete genome-scan data sets were re-
viewed at CIDR to detect binning and Mendelian errors
prior to release (see CIDR Web site, quality control).
CIDR’s procedure is to repeat genotypes only if an entire
multiplexed panel appears to have given poor results;
otherwise, likely errors are omitted from the data set.
CIDR staff rebinned the allele calls for the combined
phases 12 data set for consistency across the subsets.
Data cleaning included analysis of all genotypes with
RELCHECK (Boehnke and Cox 1997) to detect errors
in speciﬁed family relationships, which were then cor-
rected where possible (e.g., where a half-sibling rela-
tionship could be established rather than the reported
full sibling relationship). On the basis of both the fo-
rensic and RELCHECK analyses, 12 individuals were
removed (7 because of specimens that proved to be iden-
tical to other specimens, either because of MZ twinship
or sample errors, and 5 because of other incorrect re-
lationships that could not be resolved). For the complete
data set, there were 3.81% missing autosomal and X-
chromosome genotypes following QC procedures. A
total of 18,089 genotypes of blind duplicate specimens
(16 in phase 1 and 12 in phase 2, analyzed with different
PCRs but in the same experimental run) produced 13
discordant genotypes (0.072%) for ∼0.04% error per
analysis. Mendelian inconsistencies were detected for
0.37% of genotypes, primarily from the families with
pedigree relationship errors that were corrected as de-
scribed above. For all remaining Mendelian inconsisten-
cies, the genotypes for the marker were removed for all
members of the family. Finally, the data were tested for
unlikely genotypes with the use of SIBMED (Douglas et
al. 2000), and genotypes inferred to have 70% prob-
ability of being errors were deleted. All genetic locations
are on the deCode map (Kong et al. 2002).
Statistical Analysis
Primary linkage analysis.—The planned primary anal-
ysis was a model-free multipoint linkage analysis, in-
cluding only MDD cases, with the use of ALLEGRO
(Gudbjartsson et al. 2000a) to compute the Z likelihood
ratio (Zlr) score, computed for all possible informative
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Table 2
Sample Sizes and Pair Types by Site
NO. AT SITE
SAMPLE GROUP JHU Rush Iowa NYSPI Penn Pitt All
Pedigrees (MDD-RE only) 29 46 61 27 55 79 297
Individuals:
Affected individuals (MDD-RE) 92 123 165 67 146 216 809
Other genotyped individuals 36 37 44 20 56 37 230
All genotyped individuals 128 160 209 87 202 253 1,039
Possible informative pair types:
Full-sibling 74 67 128 38 112 117 536
Half-sibling 2 6 3 0 2 6 19
Grandparental 0 2 1 0 0 11 14
Avuncular 13 14 12 2 17 40 98
First cousin 0 0 0 4 2 8 14
Other 0 0 0 0 0 4 4
Total informative pairs 89 89 144 44 133 186 685
Parent-offspring pairs 34 36 23 14 21 62 190
NOTE.—Number of pedigrees, genotyped affected and other individuals, and genotyped af-
fected pairs (counting all possible pairs) included in the sample. MDD-RE cases are considered
affected, and BP-II cases are counted among the other genotyped individuals. Families with no
linkage information under the MDD model were excluded from these counts. There were 415
independent affected sibling pairs (full- and half-sib pairs) counting S-1 pairs for S affected
siblings in a sibship.
relative pairs under an exponential model (Kong and
Cox 1997), and its associated LOD score ( 4.6). Fam-2Z /lr
ilies were weighted by the square root of the SD of their
score function under the null hypothesis of no linkage,
which is considered about midway between weighting
each pair equally versus weighting each family equally
(Gudbjartsson et al. 2000b). Genomewide signiﬁcance
levels were estimated by simulating 5,000 replicates of
each chromosome, in the absence of linkage, with the
use of the actual family structures, allele frequencies, and
marker maps. Replicate “genomes” were created by ran-
domly selecting a replicate of each chromosome. The
average number of “hits” per genome was recorded
(peaks exceeding the observed Zlr). Here, “peaks” were
deﬁned as local maxima in the multipoint Zlr statistic,
30 cM apart.
Secondary analyses.—Secondary analyses included re-
computation ofZlr scores for European-ancestry families
and then for all families with BP-II cases considered af-
fected, and a series of logistic regression analyses of the
effects of a series of covariates on allele sharing in af-
fected relative pairs. The MDDBP-II model yielded
very similar results (not presented here). It is beyond the
scope of this paper to present the full set of covariate
analyses. However, because sex-speciﬁc MDD linkage
has been reported in other studies (Zubenko et al. 2002,
2003; Abkevich et al. 2003), we present here the results
of the analysis of sex as a covariate. In brief, the ap-
proach was that of Rice (1997), further developed by
Holmans (2002) and extended here to consider all types
of affected relative pairs. The multipoint likelihood of
the marker data of an affected relative pair at any point
in the genome (Risch 1990; Olson 1999) is computed
on the basis of the prior and posterior (conditional on
the observed marker data) probabilities that pair i share
j alleles identity-by-descent (IBD), obtained with the use
of ALLEGRO (Gudbjartsson et al. 2000a). The prob-
ability PR that a relative pair of type R share an allele
from a common ancestor IBD can then be expressed as
a logistic regression on two regression parameters: a (a
measure of the divergence of IBD from the null in the
sample, without allowing for covariate effects) and b (a
factor with three levels corresponding to the status of
the pair with respect to the covariate), together with a
ﬁxed offset (to ensure that PR takes its correct value in
the absence of linkage or covariate effects). A likelihood
can be obtained then as a function of PR and maximized
with respect to the parameters a and b (Holmans 2002).
Here, we test for the effect of a binary covariate (male-
male, male-female, and female-female pairs) by maxi-
mizing the likelihood with respect to a alone, and then
with respect to both a and b, to give a LOD score for
the effect of the covariate (allowing for linkage):
ˆ
ˆL(a,b)
LODp log .( )10
ˆL(a,bp 0)
The maximum value on each chromosome was com-
puted. Empirical P values (5,000 replicates) were deter-
mined genomewide for the LOD score for linkage al-
lowing for covariate effects taking both a and b into
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Table 3
Affected Pairs by Sex
NO. BY SEX
PAIR TYPE Male-Male Male-Female Female-Female All
Informative pair type:
Full-sibling 35 155 346 536
Half-sibling 1 3 15 19
Grandparental 0 6 8 14
Avuncular 2 38 58 98
First-cousin 4 9 1 14
Other 0 4 0 4
All informative pairs 42 215 428 685
Parent-offspring 8 71 111 190
account (and comparing it to the LOD score with
), and chromosomewide for the covariate ef-ap bp 0
fect (b). The former were computed by simulating rep-
licate samples in the absence of linkage. The latter were
computed by ﬁxing the observed genotypes and ran-
domly permuting covariate values among the affected
individuals. Genomewide signiﬁcance levels cannot be
simulated directly for the covariate effect because sig-
niﬁcance depends not only on the value of the LOD
score, but also on the linkage evidence present without
allowing for the covariate; in other words, a LOD score
for covariate effects on a chromosome with strong ev-
idence for linkage will be more signiﬁcant than the same
LOD score on a chromosome showing no evidence for
linkage. For very small chromosomewide P values, an
approximate genomewide signiﬁcance level could be ob-
tained by multiplying the chromosomewide P by the
total length of the genome divided by the length of the
chromosome on which the effect was observed.
For chromosome 15, where signiﬁcant evidence for
linkage was observed, heterogeneity in allele sharing in
affected pairs across the six clinical sites was tested by
introducing a covariate for each site and maximizing the
likelihood of the data while allowing the IBD probabil-
ities to differ across sites. The chromosomewide signif-
icance of the resulting likelihood-ratio statistic was as-
sessed by randomly permuting the site designations
among the pedigrees and repeating the analysis. This
procedure allows for the dependence between affected
relative pairs from the same pedigree. The analysis was
performed for affected sibling pairs and then for all in-
formative affected relative pairs.
Power analysis.—The study was designed to collect a
sample that included 900–1,000 independent ASPs, on
the basis of power analyses (Levinson et al. 2003) dem-
onstrating that a sample of this size could detect ge-
nomewide signiﬁcant linkage with 80%–90% power for
dominant and recessive models predicting a relative risk
to probands’ siblings (lsibs) of 1.30, when 5-cM marker
spacing was achieved in candidate regions. The results
are in good agreement with those of Hauser et al. (1996),
who reported that a sample of ∼400 ASPs (such as the
sample reported here) would have 80% power to detect
signiﬁcant linkage if . Although lsibs predictsl ≈ 1.8sibs
power to detect linkage for simple ASP families, for fam-
ilies with three or more affected individuals in diverse
constellations, power will depend on the (unknown) true
parameters of the full transmission model.
Results
Sample Characteristics
There were 1,057 genotyped DNA specimens from
304 eligible families. The sample included 819 individ-
uals with ﬁnal diagnoses of recurrent, early-onsetMDD,
as deﬁned above, 14 individuals with ﬁnal diagnoses of
BP-II, and 224 individuals without eligible diagnoses. In
the remainder of this paper we consider only the 297
families that were informative for linkage, with only
MDD-RE cases considered affected, as shown in table
2. In these families, there were 1,039 genotyped indi-
viduals, including 809 MDD cases and 230 individuals
without eligible MDD diagnoses (including the BP-II
cases in these families). The 809 cases included 297 pro-
bands, 388 sibs, 5 half sibs, 56 parents, 27 children, 20
nieces/nephews, 9 aunts/uncles, 2 grandparents, 2 cous-
ins, 2 spouses, and 1 other relative of probands. The
230 other genotyped individuals included 69 sibs (4 of
the BP-II cases), 1 half sib, 130 parents, 11 children (3
of them BP-II cases), 7 spouses, 5 nieces/nephews, 1
grandparent, 3 aunts/uncles, and 3 other relatives. There
were 415 independent ASPs, counting S-1 pairs from S
affected siblings in a sibship, and 685 informative rel-
ative pairs, counting all possible pairs (555 ASPs and
130 other pair types), with the breakdown by sex as
shown in table 3.
Clinical characteristics have been described elsewhere
(Levinson et al. 2003). In brief, the mean age at onset
was 18.5 years ( ), the mean number of MDDSDp 17.3
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Figure 1 Genome scan results (MDD-RE). The line represents the value of Zlr at each point on the multipoint map across the genome,
in cM. Vertical bars separate the chromosomes (chromosome numbers are shown at the bottom of the graph area). Signiﬁcant linkage was
observed on chromosome 15q (103.2 cM).
episodes (lifetime) was 7.3 ( ), and the meanSDp 9.5
longest major depressive episode during the subject’s life
was 655 d ( ). The mean age at interview wasSDp 1113
41.9 years ( ). MDD cases were 79% femaleSDp 12.3
and 95% of European ancestry; the remaining caseswere
of African American, Hispanic, or Asian ancestry. Com-
orbid diagnoses included: alcohol and substance depen-
dence, not including nicotine (22% of cases); alcohol or
substance abuse (19%); panic disorder (28%); social
phobia (15%); obsessive-compulsive disorder (9%); and
nicotine dependence (18%).
Primary Linkage Analysis Results
The multipoint graph of Zlr across the genome is
shown in ﬁgure 1. Maximum Zlr scores on each chro-
mosome are shown in table 4, together with their
deCODE locations in cM (Kong et al. 2002), the equiv-
alent LOD score, and the number of peaks per genome
expected to reach the observed value in the absence of
linkage, where peaks are deﬁned as local maxima of the
multipoint Zlr score, 30 cM apart. Genomewide levels
of signiﬁcance are deﬁned here by the average number
of P values exceeding a certain threshold that are ex-
pected per genome by chance, as determined by simu-
lation. The peak on chromosome 15q25.3-26.2 (Z plr
, equivalent LOD p 3.73) is associated with an4.14
empirical genomewide (table 4), a signiﬁcantPp .023
result (Lander and Kruglyak 1995). The nominal (un-
corrected) signiﬁcance level reported by ALLEGRO was
. The peak LOD score was observed atPp .000017
103.4 cM on the deCode map, between markers
D15S652 (99.9 cM; 90,247,135 Mb on build 34 of the
Human Genome Project [NCBI]) and D15S816 (110.9
cM; 92,749,552 Mb). No other peak was associated
with signiﬁcant or suggestive evidence for linkage. Also
listed is a second peak on chromosome 15 near D15S165
(15q13.1, ∼22.6 cM; 28,976,675 Mb), which was the
second-largest peak in the genome, but more than one
peak of this size would be expected by chance in a ge-
nome scan. With the exception of the peak on distal
15q, the observed results are consistent with what would
be expected in the absence of disease-susceptibility loci
(table 5). The multipoint graph of Zlr on chromosome
15 is shown in more detail in ﬁgure 2. The peak Zlr score
of 4.14 was observed at 103.2 cM, between D15S652
(99.92 cM, 90.1 Mb) and GATA128A02 (108.21 cM,
92.1 Mb). The 1-LOD support interval extends from a
point distal to D15S655 (92.08 cM, 85.56 Mb on build
33), to a point proximal to D15S657 (116.48 cM, 94.29
Mb), a region of ∼24 cM of genetic distance but !9 Mb
of physical distance. When the analysis was restricted to
the 286 families of predominantly European ancestry,
the peak Zlr on 15q was 4.50 (103.2 cM), with an equiv-
alent LOD of 4.39. There were too few families of non-
European ancestry to analyze separately.
Effects of Sex of the Affected Pair
This analysis considered allele sharing in all possible
informative affected relative pairs, ﬁrst with no covariate
effect and then with sex as a covariate. Note that,
whereas the LOD scores shown in table 4 were com-
puted as described above (see “Primary Linkage Anal-
ysis”), the LOD scores shown in table 6 were computed
using the likelihood-ratio method described above (see
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Table 4
Maximum Zlr Score on Each Chromosome
CHROMOSOME MAX Zlr LOD SCORE
LOCATION
(cM)
EXPECTED
GENOMEWIDE HITS
1 2.11 .97 211.2 6.6
2 1.59 .55 67.5 15.6
3 1.33 .38 117.3 22.1
4 1.06 .24 189.4 30.2
5 2.35 1.20 193.6 4.1
6 1.00 .22 63.5 32.1
7 1.43 .44 128.1 19.4
8 2.22 1.07 37.7 5.3
9 1.96 .84 72.1 8.6
10 1.44 .45 121.8 19.1
11 .39 .03 79.3 77.5
12 .27 .02 87.7 57.9
13 1.41 .43 113.0 19.9
14 .00 .00 110.4 66.8
15 2.73 1.62 22.6 1.8
15 4.14 3.73 103.2 .023
16 .51 .06 65.1 49.4
17 1.70 .63 28.0 13.2
18 1.17 .30 110.6 26.7
19 .81 .14 83.4 38.7
20 1.87 .76 2.5 10.0
21 .10 .00 29.5 69.9
22 .91 .18 8.4 35.2
X 1.01 .22 14.4 31.8
NOTE.—Maximum Zlr scores on each chromosome from the analysis ofMDD,
together with locations (cM on deCODEmap) and the expected number of peaks
in a genome scan at least as large as the observed value in the absence of disease
loci (“hits”). Two scores are listed for chromosome 15 because these were the
two largest scores in the genome (largest score in bold italics).
Table 5
Expected versus Observed
Peaks Given Zlr Values
NO. OF PEAKSa
Zlr Expected Observed
0.5 49.7 42
1.0 32.1 26
1.5 17.7 10
2.0 8.1 5
2.5 3.1 2
3.0 1.0 1
3.5 .24 1
4.0 .04 1
4.5 .009 0
5.0 .001 0
a Under the assumption of
no disease loci in the genome.
“Secondary Analyses”). Thus, the peak LOD score on
chromosome 15q without covariates was 3.73 in the
former and 5.8 in the latter analysis, but the empirical
levels of signiﬁcance are similar.
Table 6 lists the four peaks for which a suggestive
(expected once per genome scan) or signiﬁcant (P !
per genome scan) effect was observed for the overall.05
LOD score taking sex into account. Note, however, that
these P values have not been corrected for the number
of secondary analyses, and must be considered hypoth-
esis generating. Shown are the LOD scores, with and
without covariates; the peak location and nearest
marker; the pair type that produced evidence for link-
age; the expected number of genomewide scores as large
as the observed LOD for linkage, taking the covariate
into account; and the empirical chromosomewide P
value for the covariate effect (in effect, for the increased
evidence for linkage when the covariate is taken into
account). The covariate effect was nominally signiﬁcant
( ) on chromosomes 6, 15, and 17, but not onP ! .05
chromosome 8. The highest IBD proportion was seen in
male-male pairs for three of the chromosomes: chro-
mosome 6 (male-male IBD p .66, male-female p .42,
female-femalep .52), chromosome 8 (male-malep .66,
male-female p .54, female-female p .54), and chro-
mosome 17 (male-male p .67, male-female p .58, fe-
male-female p .50). These results should be regarded
with caution, because of the small number of male-male
pairs in the sample. On chromosome 15, the LOD score
reached genomewide signiﬁcance without the covariate
effect, and the covariate produced a modest increase in
the evidence for linkage (nominal ), with thePp .02
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Figure 2 Linkage analysis of chromosome 15 (MDD-RE). The blackened circles and dark black line represent Zlr scores (left Y-axis)
across the multipoint map of chromosome 15 in cM. The lighter line represents ALLEGRO’s information content measure (right Y-axis).Marker
names are shown at the bottom of the graph area.
highest IBD observed in male-female pairs (.67), com-
pared with female-female (.58) and male-male (.50)
pairs.
Cross-Site Heterogeneity Analysis
In tests for cross-site heterogeneity in linkage evidence
on chromosome 15, chromosomewide P values of .41
and .40 were obtained with the use of all affected relative
pairs and ASPs, respectively. Thus, there is no evidence
that observed differences in linkage evidence between
sites are caused by anything other than stochastic
variation.
Discussion
The most striking result observed in this study is the
genomewide signiﬁcant linkage with the MDD-RE phe-
notype at 103.2 cM on chromosome 15q. Linkage in
this region has not been reported elsewhere for MDD
or related phenotypes. It would be premature to spec-
ulate about the gene or genes in this region that could
be producing this linkage signal, because of the imprecise
localization of signals in linkage studies of complex dis-
orders (Roberts et al. 1999) and because some of the
most promising candidate genes discovered by positional
cloning studies of neuropsychiatric disorders, such as
schizophrenia, either have been previously unknown, as
in the case of G72 (Chumakov et al. 2002), or had not
been predicted to be involved in the disorder of interest,
as in the case of dysbindin (Straub et al. 2002) and
neuregulin 1 (Stefansson et al. 2002). Systematic linkage
ﬁne-mapping and linkage disequilibrium-mapping stud-
ies of this region will be needed. The analysis of the
effect of sex on linkage to MDD was nominally signif-
icant, but we are not aware of a biological explanation
for the observation that male-female pairs showed the
highest IBD sharing, and, therefore, we cannot conclude
that there is a sex-speciﬁc effect in this region. No sig-
niﬁcant cross-site heterogeneity was observed in the ev-
idence for linkage to chromosome 15q.
In secondary analyses (not corrected for multiple test-
ing), suggestive evidence for linkage was observed,when
sex effects were taken into account, on chromosomes
6q, 8p, and 17p, with male-male pairs showing the high-
est IBD sharing in each of these regions. The low num-
ber of male-male pairs suggests that these results could
be spurious. However, it is plausible that, since MDD
is more prevalent in females, it could require a greater
genetic loading to produce a male-male affected relative
pair, and, thus, there could be loci at which it is nec-
essary for a male (but not a female) to possess a par-
ticular allele to become affected and at which IBD shar-
ing will be higher in male-male pairs.
There have been two other published genome scans
of major depression (Zubenko et al. 2002, 2003; Ab-
kevich et al. 2003), and one of neuroticism (Fullerton
et al. 2003), a related trait. Zubenko et al. (2002, 2003)
reported a 10-cM genome scan of 81 families ascer-
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Table 6
Evidence for Linkage With and Without Accounting for the Effect of Sex of the Pair as a Covariate
LOD
CHROMOSOME No Covariates  Sex
DISTANCE
(cM) NEAREST MARKER LINKED PAIRS
EXPECTED NO. OF
PEAKS GENOMEWIDE
(LOD  SEX)
CHROMOSOMEWIDE P
(COVARIATE EFFECT)
6 .26 3.66 80.2 D6S1053 M-M .25 .002
8 1.76 2.81 38.3 D8S560 M-M .80 .17
15 5.80 7.57 102.1 D15S652 M-F, F-F !.01 .02
17 1.04 3.09 27.0 D17S974 M-M, M-F .54 .015
NOTE.—Chromosomes and covariates for which LOD  sex (LOD score for linkage including the effect of the sex of the pair as a covariate
effect) reached the genomewide “suggestive” level (i.e., a level that was expected to be observed at least one time genomewide in the absence
of linkage). The last column shows the chromosomewide P value for a direct test of the covariate effect (LOD sex vs. LOD with no covariates),
along with the pair type(s) showing the greatest evidence for linkage. These are secondary analyses and do not include all of the covariate
effects that were tested (see main text). P values have not been corrected for multiple testing. Note that these LOD scores were computed by
a different method than were those shown in table 4 (see main text).
tained through MDD-RE probands. Their ascertain-
ment criteria differed from those of the present study
in that (1) probands had nonpsychotic MDD with AO
25 years, (2) pedigrees were chosen if two parents and
at least one sibling were willing to participate but with-
out regard to the relatives’ diagnoses, and (3) diagnoses
were based on SADS interviews and RDC criteria
(Spitzer and Endicott 1975; Spitzer et al. 1978); note
that there was no overlap between this earlierstudy and
the present one, that is, no families collected at the Uni-
versity of Pittsburgh were included in both studies. Zu-
benko et al. (2003) performed logistic regression allele-
sharing analyses in affected relative pairs with and
without two covariates (sex and observation of LOD
10 at a marker on chromosome 2q with evidence for
linkage in the sample) under ﬁve phenotypic models
ranging from MDD-RE (135 all possible affected rel-
ative pairs) to all mood disorders (620 pairs). Positive
evidence for linkage was observed near both of the chro-
mosome 15q linkage peaks reported here: the linkage
model without covariates giving a LOD p 1.96 for
recurrent MDD (240 pairs) at 38 cM on the deCODE
map, near our second-largest peak (22.6 cM), whereas
inclusion of covariates gave LODs 14.0 for both the
MDD-RE and recurrentMDD phenotypes at ∼110–125
cM (deCODE map), near our signiﬁcant peak (103.2
cM). The largest LOD score without covariate effects
(4.2) was on chromosome 11pter for recurrent MDD.
The most signiﬁcant evidence for linkage with covari-
ates was observed on chromosome 2q (stronger evi-
dence in females). Several interactions were observed
between 2q and other regions.
Abkevich et al. (2003) typed 628 microsatellite mark-
ers in 110 Utah families with four or more available
affected cases, ascertained through MDD probands.
The clinical model was somewhat different from that
of the present study: diagnoses were established with
the use of a modiﬁed CIDI interview, an interview sched-
ule that was designed for epidemiological research
(Robins et al. 1988), and BP-I and BP-II cases (15% of
the sample) were all considered affected with the “de-
pression” phenotype that produced the signiﬁcant re-
sult. Linkage was analyzed separately for all cases, and
then for only male or only female cases considered af-
fected. One genomewide signiﬁcant result was observed,
in male cases only, on chromosome 12q22-q23.2, where
evidence for linkage to bipolar disorder has been re-
ported elsewhere (Craddock et al. 1994; Dawson et al.
1995; Morissette et al. 1999; Ewald et al. 2002; Jones
et al. 2002). No evidence for linkage was observed on
chromosome 15q. In the present study, logistic regres-
sion analysis in the 12q linkage region reported by Ab-
kevich et al. demonstrated a LOD score of ∼0 that rose
to 1.03 when sex was taken into account. This result
was not statistically signiﬁcant, but the pattern of IBD
sharing is of interest: .59 in male-male pairs versus .45
for male-female and .50 for female-female pairs. Thus,
it could require a much larger sample of male-male pairs
to test the Abkevich et al. ﬁnding.
Fullerton et al. (2003) performed a genome scan in
559 sibling pairs who were concordant or discordant
for neuroticism scores in the top or bottom 2.5% of
standardized scores, drawn from ∼20,000 sibships
screened through primary care medical practices. A sub-
stantial overlap has been estimated between the genetic
factors underlying MDD and neuroticism (Kendler et
al. 1993a; Clark et al. 1994; Duggan et al. 1995; Fava
et al. 1996; Enns and Cox 1997). Signiﬁcant evidence
for linkage was observed on chromosomes 1q, 4q, 7q,
8p, 11q, 12q, and 13q. The 12q peak was at essentially
the same location as the signiﬁcant result reported by
Abkevich et al. (2003), except that the neuroticism link-
age was observed primarily in females rather than in
males. The 11q peak was within 15 cM of a peak re-
ported by Zubenko et al. (2003); neither result was
associated with sex effects.
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Only one broad chromosomal region received atten-
tion in three different studies: chromosome 8p produced
the seventh-strongest result (8 cM) in Fullerton et al.
(2003), the fourth-strongest result (37.7 cM) in the pre-
sent study, and one of the four most positive results for
the narrowest diagnostic model (60 cM) in the work of
Zubenko et al. (2003). However, the latter two results
were not signiﬁcant, and the ﬁrst and third results are
quite far apart. The inconsistent results for MDD are
typical of complex disorders, for which replication of
linkage is difﬁcult. It is hoped that additional large sam-
ples will produce more convergent results across studies,
as has been the case for schizophrenia (Lewis et al.
2003).
In conclusion, we have reported genomewide signif-
icant evidence for linkage to recurrent, early-onset
MDD on chromosome 15q. This region deserves further
study attempting to identify the gene or genes under-
lying the evidence for linkage. Positional cloning meth-
ods have the potential to elucidate the pathophysiology
of this common and debilitating disorder.
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